论文部分内容阅读
目的探讨产后出血的最佳预防和治疗方案。方法选择足月妊娠、正常分娩、单胎、头位、无妊娠合并症及妊娠并发症的产妇392例,随机分为观察组和对照组,每组196例。观察组为胎儿娩出后米索前列醇联合缩宫素给药;对照组为单纯缩宫素给药。观察第三产程时间、产后2 h出血量、产后出血率。结果观察组第三产程时间明显缩短,产后2 h出血量、产后出血发生率明显减少,2组比较差异有统计学意义(P<0.01)。结论 米索前列醇联合缩宫素能有效减少产后出血量,预防、降低产后出血率,对于防治产后出血,疗效明显优于单用缩宫素,是防治产后出血的最佳方案,值得临床推广使用。
Objective To explore the best prevention and treatment of postpartum hemorrhage. Methods 392 pregnant women with full-term pregnancy, normal delivery, single birth, head position, pregnancy-free complication and pregnancy complications were randomly divided into observation group and control group with 196 cases in each group. The observation group was given misoprostol combined with oxytocin after the fetus was delivered; the control group was administered oxytocin only. Observation of the third stage of labor time, 2 h postpartum hemorrhage, postpartum hemorrhage rate. Results The duration of the third stage of labor was significantly shortened in the observation group. The amount of hemorrhage and the incidence of postpartum hemorrhage were significantly decreased at 2 h postpartum. The difference between the two groups was statistically significant (P <0.01). Conclusions Misoprostol combined with oxytocin can effectively reduce the amount of postpartum hemorrhage and prevent and reduce the rate of postpartum hemorrhage. It is superior to oxytocin alone in preventing and treating postpartum hemorrhage. It is the best way to prevent postpartum hemorrhage and is worthy of clinical promotion use.